- Autores: Magdalena Szydłowicz, Olga Matos
- Ano de Publicação: 2021
- Journal: Trends in Parasitology, 37(10), pp 859 - 862
- Link: https://doi.org/10.1016/j.pt.2021.07.010
The clinical picture of the fungal disease, Pneumocystis pneumonia, resembles the course of coronavirus disease 2019 (COVID-19), presenting a diagnostic challenge in the pandemic era. We discuss the concern of Pneumocystis jirovecii and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coinfection, their similarities, and the impact of immunosuppression, with a suggested diagnostic pathway for their suspected coinfection.